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Abstract: The whole plants of Ypsilandra thibetica have been analyzed as part of a systematic study on saponin constituents of 
medicinal plants. This has resulted in the isolation of two new bisdesmosidic furostanol saponins, named ypsilandroside P (1) and 
ypsilandroside Q (2), and one new pregnane glycoside, named ypsilandroside R (3), together with nine known steroidal glycosides. 
Their structures were elucidated on the basis of extensive spectroscopic analysis, including that of 2D NMR data, and the results of 
acidic hydrolysis. Ypsilandroside P (1) was cytotoxicity against two human tumor cell lines. 
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Introduction 
In a continuation of our study on saponin constituents of 
medicinal plants, we have examined the saponin riched  
fraction prepared from the EtOH extract of the air-dried whole 
plants of Ypsilandra thibetica (Liliaceae). This perennial plant 
distributes in southwestern China and has been used as  
hemostatic agent in Chinese folk medicine.1,2 In our recent 
study, we found that this species was a rich source of steroidal  
saponins. Two sapogenin, 22 spirostanol saponins, and two C-
22 steroidal lactone glycosides were obtained from the title 
plants.3–6 Further phytochemical investigation has been carried 
out on this species, with particular attention to the steroidal 
glycoside constituents, and has resulted in the isolation of two 
new bisdesmosidic furostanol saponins (1 and 2) and one new 
pregnane glycoside (3), together with nine known steroidal 
glycosides: protoprogenin II (4),7 proto-Pb (5),8 saponin Th 
(6),9 pseudoproto Pb (7),10 pregnane 5,16-dien-3β-ol-20-oxo 
3-O-α-L-rhamnopyranosyl-(1→4)-α-L-rhamnopyranosyl-(1→
4)-[α-L-rhamnopyranosyl-(1→2)]-β-D-glucopyranoside (8),11 
smilaxchinoside B (9),12 parispseudoside C (10),13 parispseu-
doside A (11),13 and 26-O-β-D-glucopyranosyl-3β,26-di-
hydroxy-20,22-seco-25(R)-furost-5-en-20,22-dione 3-O-α-L-
rhamnopyranosyl-(1→4)-α-L-rhamnopyranosyl-(1→4)-[α-L-
rhamnopyranosyl-(1→2)]-β-D-glucopyranoside (12).14 This 
paper reports the isolation, structural determination, and  
cytotoxic activity of these glycosides. 
 
Results and Discussion 
Compound 1, obtained as a white amorphous powder, gave 
a pseudo-molecular ion peak [M – H]– at m/z 1207.5736 (calcd. 
1207.5747) in its HRESIMS. Combined with 13C NMR 
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determined as C57H92O27. The 1H NMR spectrum of 1 (Table 1) 
showed signals of four steroid methyl groups at δH 0.97 (3H, d, 
J = 6.5 Hz, Me-27), 1.06 (3H, s, Me-19), 1.15 (3H, s, Me-18), 
and 1.53 (3H, d, J = 6.7 Hz, Me-21), an olefinic proton at δH 
5.22 (1H, br. s), as well as signals for five anomeric proton 
signals at δH 4.80 (1H, d, J = 7.7 Hz, H-1'''''), 4.93 (1H, d, J = 
7.2 Hz, H-1'), 5.84 (1H, br. s, H-1'''), 6.29 (1H, br. s, H-1''''), 
and 6.41 (1H, br. s, H-1''). The three methyl carbon signals at 
δC 18.7, 18.9, and 18.5 and their corresponding proton signals 
at δH 1.58 (3H, d, J = 5.2 Hz, H-6''), 1.58 (3H, d, J = 5.2 Hz, 
H-6'''), and 1.75 (3H, d, J = 6.1 Hz, H-6'''') indicated that 1 had 
three deoxy sugars. The monosaccharides of the acidic 
hydrolysate of 1 were identified as D-glucose and L-rhamnose 
on the basis of GC analysis and comparison with authentic 
standards. The above 1H NMR and chemical data, together 
with an acetalic carbon signal at δC 110.9 in the 13C NMR 
spectrum15 and a positive coloration with Ehrlich reagent,16,17 
indicated 1 to be a furostanol saponin with up to five 
monosaccharides. A comparison of the 1H and 13C 
spectroscopic signals of the aglycone moiety of 1 with Proto-
Pb (5)8 indicated that the signals were similar except for the 
presence of a carbonyl group (δC 213.1). In the HMBC 
spectrum (Figure 1), the long-range correlations from δH 1.15 
(Me-18, s) to δC 213.1 (C-12, s), 55.4 (C-13, s), 56.0 (C-14, d), 
and 54.9 (C-17, d) indicated that the carbonyl group was 
attached at C-12 of the aglycone of 1. The configuration of the 
methyl group at C-25 is R on the basis of the proton signals of 
C-26 at δH 3.94 (1H, 26-Ha) and 3.60 (1H, 26-Hb), and the 
difference (∆ab) of the proton signals at C-26 was 0.34.18,19 
From the above evidence, the aglycone of 1 was identified as 
(25R)-furost-5-en-3β,22α,26-triol-12-one. 
Comparison of the carbon chemical shift thus assigned with 
those of the reference methyl glycosides,15,19 taking into 
account the known effects of O-glycosylation, indicated that 1 
contained a terminal β-D-glucopyranosyl units, two terminal 
α-L-rhamnopyranosyl unit, a C-4 substituted α-L-rhamno-
pyranosyl unit, and a C-2 and C-4 disubstituted β-D-
glucopyranosyl unit. The β-configuration of the anomeric  
protons of the glucopyranosyl residue were assigned based on 
its J1H-2H value ( J = 7.2~7.7 Hz), while the anomeric 
configuration of the three rhamnopyranosyls were determined 
as α-oriented on the ground the chemical shift values of the C-
3, C-5, C-3, C-5, C-3, and C-5 with those of the 
corresponding carbons of methyl α- and β-rhamno-
pyranoside.20,21 In the HMBC spectrum, a correlation peak 
between the signals at δH 4.80 (H-1 of terminal glucosyl) and δC 75.4 (C-26 of aglycon) implied that one glucose unit was 
attached at C-26 of the aglycon, which is a structural feature 
most frequently encountered in the plant furostanol saponins.15 
Consequently, a tetraglycoside was assumed to be located at 
C-3 of the aglycon. The sequence of the tetrasaccharide, which 
was the same as the known compounds 5–12, was established 
from the further HMBC correlations: H-1 (δH 4.93) of Glc 





































Figure 1.  Selected HMBC correlations of conpound 1.
Table 1. 1H NMR spectral data for compounds 1–3 ( in ppm, J in Hz, C5D5N)a 
Pos.  1b 2c 3c Pos. 1b 2c 3c 
1a 1.96, m 1.53, m 1.47, m Glc-1′ 4.93, d (7.2) 4.91, d (7.9) 4.93, d (7.4)
1b 0.89, m 0.89, m 0.87, m  2′ 4.18, m 4.20, m 4.21, m 
2a 2.00, m  2.00, m 1.63, m 3′ 4.20, m 4.23, m 4.20, m 
2b 1.78, m 1.88, m 1.41, m 4′ 4.39, m 4.41, m 4.40, m 
3 3.81, m 3.82, m 3.81, m 5′ 3.60, br. d (9.1) 3.61, m 3.59, br. s 
4a 2.80, m 2.81, dd (11.0, 2.4) 2.82, dd (13.3, 1.8) 6′a 4.17, d (14.2) 4.17, d (12.3) 4.18, m 
4b 2.68, m 2.68, t (11.0) 2.68, dd (12.3, 5.9) 6′b 4.02, m 4.04, m 4.03, d (11.1) 
6 5.22, br. s 5.28, br. s 5.30, br. s Rha-1′′ 6.41, br. s 6.41, br. s 6.41, br. s 
7a 1.87, m  1.89, m (2H) 1.90, m 2′′ 4.86, m 4.85, m 4.85, m 
7b 1.43, m  1.52, m 3′′ 4.62, m 4.63, m 4.63, m 
8 1.85, m 1.79, m 1.86, m 4′′ 4.35, m 4.37, m 4.36, m 
9 1.30, m 1.32, m 1.38, m 5′′ 4.93, m 4.95, m 4.94, m
11a 2.56, t (13.5) 2.53, t (14.0) 2.64, t (13.5) 6′′ 1.58, d (5.2) 1.59, d (5.9) 1.59, d (5.6) 
11b 2.30, dd (14.4, 5.6) 2.31, dd (14.5, 5.7) 2.25, dd (13.5, 6.3) Rha-1′′′ 5.84, br. s 5.84, br. s 5.83, br. s 
14 1.41, m 1.23, m 1.58, m 2′′′ 4.51, m 4.51, m 4.53, m 
15a 2.09, m 2.20, m 2.25, m 3′′′ 4.55, m 4.56, m 4.55, m 
15b 1.64, m 1.67, m 2.07, m 4′′′ 4.44, m 4.45, m 4.43, m 
16 4.88, m 4.84, m 6.54, s 5′′′ 4.92, m 4.93, m 4.93, m 
17 2.94, t (7.5) 3.45, d (10.2)  6′′′ 1.58, d (5.2) 1.59, d (5.9) 1.59, d (5.6) 
18 1.15, s 0.95, s 1.33, s Rha-1′′′′ 6.29, br. s 6.30, br. s 6.29, br. s 
19 1.06, s 1.07, s 1.07, s 2′′′′ 4.90, m 4.90, m 4.90, m 
20 2.20, dd (13.2, 6.5)   3′′′′ 4.52, m 4.53, m 4.53, m
21 1.53, d (6.7) 1.74, s 2.32, s 4′′′′ 4.30, m 4.31, m 4.31, m 
23a 2.05, m 2.20, m (2H)  5′′′′ 4.36, m 4.38, m 4.36, m 
23b 1.52, m   6′′′′ 1.75, d (6.1) 1.76, d (6.2) 1.76, d (6.2) 
24a 2.04, m 1.89, m  Glc-1′′′′′ 4.80, d (7.7) 4.84, d (7.8)  
24b 1.66, m 1.45, m  2′′′′′ 3.60, br. d (9.1) 3.60, dd (9.4, 5.4)  
25 1.92, m 1.93, m  3′′′′′ 4.24, m 4.26, m  
26a 3.94, dd (9.1, 7.1) 3.95, dd (9.4, 7.1)  4′′′′′ 4.21, m 4.25, m  
26b 3.60, dd (9.1, 5.8 ) 3.59, dd (9.4, 5.4)  5′′′′′ 3.94, m 3.96, m  
27 0.97, d (6.5) 1.01, d (6.6)  6′′′′′a 4.54, m 4.58, m  
    6′′′′′b 4.38, m 4.40, m  
aAssignments based on 2D NMR spectra; bRecorded at 400 MHz; cRecorded at 500 MHz. 
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with C-2 (δC 78.0) of Glc, H-1 (δH 5.84) of 4-Rha with C-4 
(δC 77.8) of Glc, and H-1 (δH 6.29) of 4-Rha with C-4 (δC 




and named ypsilandroside P. 
Compound 2 displayed a [M – H]– ion at m/z 1189.5645 
(calcd. for C57H89O26, 1189.5642) in the HRESIMS and gave a 
red color with Ehrlich’s reagent. The NMR spectral data 
suggested 2 is a furostanol saponin closely related to 1. It 
differed from 1 in the presence of one more olefinic 
functionality [δC 153.2 (s) and 103.1 (s)] in addition to the 
5(6)-en group. Furthermore, the Me-21 methyl doublet signal 
observed at δH 1.53 (J = 6.7 Hz) in the 1H NMR spectrum of 1 
was absent from 2, but was replaced by a methyl singlet at δH 
1.74. These data were suggestive of 2 being the corresponding 
20(22)-furostanol saponin of 1, which was confirmed by the 
mass difference of m/z = 18 and HMBC correlations. In the 
HMBC spectrum of 2, the correlations of Me-21 (δH 1.74) with 
C-17 (δC 56.1), C-20 (δC 103.1), and C-22 (δC 153.2) were 




glucopyranoside, and named ypsilandroside Q. 
Compound 3 had a molecular formula of C45H68O20, 
established by analysis of HRESIMS (m/z 963.3953 [M + Cl]–, 
calcd. 963.3992) and 13C NMR spectrum (45 signals). The 1H 
NMR spectrum of 3 displayed two three-proton singlet signals 
at δH 1.07 (s) and 1.33 (s), indicating the presence of two 
angular methyl groups, and a methyl singlet at δH 2.32 (s) 
attached to a deshielding moiety, as well as four anomeric 
proton signals at δH 4.93 (1H, d, J = 7.4 Hz), 5.83 (1H, br. s), 
6.29 (1H, br. s), and 6.41 (1H, br. s). The existence of an α,β-
unsaturated carbonyl group was verified by the IR (1657 cm−1), 
UV [227 nm (logε 2.8)], and 13C NMR [δC 196.0 (C=O), 150.7 
(C), and 142.8 (CH)] spectra. These spectral data and 
comparison with those of the known compound 811 indicated 
that 3 differed from 8 by the presence of a carbonyl group (δC 
209.2) instead of a methylene moiety at C-12 in the latter. The 
HMBC correlations of δH 1.33 (Me-18) with δC 209.2 (C-12, s), 
61.3 (C-13, s), 56.2 (C-14, d), 150.7 (C-17, s) indicated that 
the location of the carbonyl group at C-12. Thus, the aglycone 
of 3 was identified as 3α-hydroxypregna-5,16-dien-12,20-
dione. The 1H and 13C NMR shifts of the tetraglycoside moiety 
linked to C-3 of the pregnane were superimposable on those of 
1, 2, and 5–12. On the basis of all the information above, the 
structure of 3 was characterized as pregnane 5,16-
dien-3-ol-12,20-dione 3-O-α-L-rhamnopyranosyl-(1→4)-α-L-
rhamnopyranosyl-(1→4)-[α-L-rhamnopyranosyl-(1→2)]-β-D-
glucopyranoside, and named ypsilandroside R. 
The cytotoxic activities of saponins 1, 2, and 12 against the 
growth of human tumor cell lines (A549 and HL-60) were 
evaluated. The results indicated that only compound 1 showed 
86.4% inhibition to A549 cell lines and 75.9% inhibition to 
HL-60 cell lines at the tested concentration (10 μM). 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
measured on a Jasco P-1020 automatic digital polarimeter. UV 
spectra were measured using a Shimadzu UV-2401PC spec-
trophotometer. IR spectra were measured on a Bio-Rad FTS-
135 spectrometer with KBr pellets. NMR spectra were run on 
Bruker AM-400 and DRX-500 instruments with TMS as  
Table 2. 13C NMR spectral data for compounds 1–3 (C5D5N) 
Pos. 1a 2b 3b Pos. 1a 2b 3b
1 37.2, CH2 37.1, CH2 37.0, CH2 Glc-1′ 100.4, CH 100.4, CH 100.4, CH
2 30.0, CH2 30.0, CH2 29.9, CH2 2′ 78.0, CH 77.9, CH 78.0, CH 
3 77.8, CH 77.9, CH 77.9, CH 3′ 77.7, CH 77.7, CH 77.8, CH 
4 38.8, CH2 38.8, CH2 38.8, CH2 4′ 77.8, CH 77.8, CH 77.9, CH 
5 140.6, C 140.7, C 141.1, C 5′ 77.1, CH 77.1, CH  77.1, CH 
6 121.7, CH 121.6, CH 121.5, CH 6′ 61.2, CH2 61.3, CH2 61.3, CH2 
7 31.9, CH2 31.9, CH2 31.4, CH2 Rha-1′′ 102.3, CH 102.2, CH 102.2, CH 
8 31.0, CH 30.8, CH 30.2, CH 2′′ 72.6, CH 72.5, CH 72.5, CH 
9 52.4, CH 52.4, CH 53.8, CH 3′′ 72.7, CH 72.6, CH 72.7, CH 
10 37.7, C 37.8, C 38.0, C 4′′ 74.2, CH 74.1, CH 74.2, CH 
11 37.6, CH2 37.7, CH2 37.8, CH2 5′′ 69.5, CH 69.6, CH 69.6, CH 
12 213.1, C 212.8, C 209.2, C 6′′ 18.7, CH3 18.7, CH3 18.7, CH3
13 55.4, C 57.2, C 61.3, C Rha-1′′′ 102.3, CH 102.3, CH 102.3, CH 
14 56.0, CH 54.4, CH 56.2, CH 2′′′ 72.9, CH 72.9, CH 72.9, CH 
15 31.9, CH2 34.0, CH2 31.8, CH2 3′′′ 73.4, CH 73.3, CH 73.3, CH 
16 79.8, CH 83.1, CH 142.8, CH 4′′′ 80.5, CH 80.4 , CH 80.4, CH 
17 54.9, CH 56.1, CH 150.7, C 5′′′ 68.4, CH 68.4, CH 68.4, CH 
18 16.1, CH3 14.0, CH3 16.4, CH3 6′′′ 18.9, CH3 18.9, CH3 18.8, CH3 
19 19.0, CH3 18.9, CH3 18.9, CH3 Rha-1′′′′ 103.4, CH 103.3, CH 103.3, CH 
20 41.4, CH 103.1, C 196.0, C 2′′′′ 72.7, CH 72.6, CH 72.5, CH 
21 15.3, CH3 11.6, CH3 27.7, CH3 3′′′′ 72.9, CH 72.9, CH 72.9, CH 
22 110.9, C 153.2, C  4′′′′ 74.0, CH 74.0, CH 74.1, CH
23 37.1, CH2 23.8, CH2  5′′′′ 70.5, CH 70.4, CH 70.5, CH 
24 28.4, CH2 31.4, CH2  6′′′′ 18.5, CH3 18.5, CH3 18.5, CH3 
25 34.3, CH 33.6, CH  Glc-1′′′′′ 105.0, CH 105.0, CH  
26 75.4, CH2 75.2, CH2  2′′′′′ 75.3, CH 75.0, CH  
27 17.5, CH3 17.3, CH3  3′′′′′ 78.7, CH 78.6, CH  
    4′′′′′ 71.7, CH 71.7, CH  
    5′′′′′ 78.6, CH 78.5, CH  
    6′′′′′ 62.9, CH2 62.9, CH2  
aRecorded at 100 MHz; bRecorded at 125 MHz. 
14      H. Y. LIU et al.                                                                                                                             Nat. Prod. Bioprospect. 2012, 2, 11–15 
 
         
internal standard. FAB-MS spectra were recorded on a VG 
Auto Spec-300 spectrometer, HRESIMS spectra were recorded
on an API Qstar Pulsar instrument. Column chromatography 
(CC) was performed over silica gel (200–300 mesh, 10–40 μm, 
Qingdao Marine Chemical Co., China), Rp-18 (40–63 μm, 
Merck), and Sephadex LH-20 (GE Healthcare, Sweden). TLC 
was performed on HSGF254 (0.2 mm, Qingdao Marine  
Chemical Co., China) or Rp-18 F254 (0.25 mm, Merck). Semi-
preparative HPLC was run on Agilent 1100 liquid  
chromatograph with diode array detector (DAD) setting at 
200nm and 254 nm, ZORBAX SB-C18 (5 μm) column (25 cm 
× 9.4 mm i.d.). GC analysis was performed on a Shimadzu 
GC-2010 gas chromatograph equipped with an H2 flame  
ionization detector. 
 
Plant Material. The plant material of Y. thibetica was  
collected in November 2006 from Luding County, Sichuan 
Province, China, and identified by Prof. Xin-Qi Chen, Institute 
of Botany, Chinese Academy of Sciences, Beijing. A voucher 
specimen (No. HY0002) was deposited at the State Key  
Laboratory of Phytochemistry and Plant Resources in West 
China. 
 
Extraction and Isolation. The air-dried whole plants of Y. 
thibetica (10 kg) were extracted three times with 70% EtOH 
(50 L × 3) under reflux for a total of 6 h and the combined 
extract was concentrated under reduced pressure. Then the 
concentrated extract was loaded onto a macroporous resin 
column (YWD-3F) and eluted successively with H2O, 40% 
EtOH (F1 fraction), 70% EtOH (F2 fraction), and 95% EtOH 
(F3 fraction), respectively. The 40% EtOH elutes were  
evaporated to dryness. Fraction F1 (33 g) was fractioned by 
silica gel column and eluted with a gradient of CHCl3-MeOH-
H2O (8:2:0.2→7:3:0.5, v/v) to get two subfractions (F11 and 
F12). Fraction F11 was subjected to column chromatography 
on Rp-18 gel (MPLC, MeOH-H2O 4:6→6.5:3.5) and semi-
preparative HPLC (MeOH-H2O 38:62 v/v; flow rate: 3 
mL.min−1) to obtain 3 (14 mg), 4 (28 mg), and 8 (19 mg). 
Fraction F12 was chromatographed over Rp-18 gel (MPLC, 
MeOH-H2O 3:7→7:3) and semi-preparative HPLC (MeCN-
H2O 20:80→35:65 v/v; flow rate: 3 mL.min−1) to yield 1 (17 
mg), 2 (8 mg), 5 (43 mg), 6 (80 mg), 7 (23 mg), 9 (20 mg), 10 
(17 mg), 11 (18 mg), and 12 (24 mg). 
 
Ypsilandroside P (1): white amorphous powder; [α] 24D   
−65.0 (c 0.26, MeOH); IR (KBr) νmax 3431, 2934, 1706, 1640, 
1453, 1381, 1130, 1044, 985, 911, 839, 804 cm−1 (intensity: 
839 > 911); 1H and 13C NMR data see Tables 1 and 2; negative 
FABMS m/z 1208 [M]−, 1062 [M − 146]−, 915 [M − H − 2 × 
146]−, 769 [M − H − 3 × 146]−; negative ion HRESIMS m/z 
1207.5736 (calcd. for C57H91O27 [M − H]−, 1207.5747). 
 
Ypsilandroside Q (2): white amorphous powder; [α] 24D   
−66.8 (c 0.47, MeOH); IR (KBr) νmax 3426, 2933, 1707, 1640, 
1453, 1382, 1131, 1043, 984, 911, 841, 804 cm−1 (intensity: 
841 > 911); 1H and 13C NMR data see Tables 1 and 2; negative 
FABMS m/z 1190 [M]−, 1043 [M − H − 146]−, 897 [M − H − 
2 × 146]−; negative ion HRESIMS m/z 1189.5645 (calcd. for 
C57H89O26 [M − H]−, 1189.5642). 
Ypsilandroside R (3): white amorphous powder; [α] 22D   
−58.3 (c 0.12, MeOH); UV (MeOH) λmax (log ε) 227 (2.8) nm; 
IR (KBr) νmax 3418, 2934, 1713, 1657, 1376, 1132, 1053, 983 
cm−1; 1H and 13C NMR data see Tables 1 and 2; negative 
FABMS m/z 927 [M − H]−, 781 [M − H − 146]−, 635 [M − H 
− 2 × 146]−; negative ion HRESIMS m/z 963.3953 (calcd. for 
C45H68O20Cl [M + Cl]−, 963.3992). 
 
Acid Hydrolysis of Compounds 1–3 and GC Analysis. 
Compounds 1–3 (4 mg each) were refluxed with 4 M TFA-
dioxane (1:1 v/v, 2 mL) on water bath for 4h. The reaction 
mixture was neutralized with 1 M NaOH and filtered. The 
filtrate was extracted with CHCl3 and H2O. The H2O-soluble 
fraction was evaporated to dryness. The dried sugar residues 
was diluted in 1 mL pyridine without water and treated with 
0.5 mL trimethyl-chlorsilan (TMCS) and stirred at 60°C for 5 
min. After drying the solution with a stream of N2, the residue 
was extracted with ether (1 mL). The ether layer was analyzed 
by GC under the following conditions: column, SGE AC-10 
quartz capillary column (30 m × 0.32 mm × 0.25 μm); column 
temperature 180–280°C; programmed increase, 3 °C/min; 
carrier gas, N2 (2 ml/min); injector and detector temperature, 
250°C; injection volume, 2 μL; split ratio, 1/50. Peaks of the 
hydrolysate were detected by comparison with retention times 
of authentic samples of glucose and rhamnose after treatment 
with trimethyl-chlorsilan (TMCS) in pyridine. The absolute 
configurations of the sugar residues were determined to be L-
rhamnose (tR 7.67 min) and D-glucose (tR 14.22 min). 
 
Cell-Growth Inhibition Assay. Growth inhibition of 
compounds on tumor cells was determined by microculture 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium hydro-
bromide (MTT) assay.22 
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